Position in NVS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$3,170,602
+$39,533 QoQ
Shares Held
20,231
-1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#338
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BEACON FINANCIAL GROUP holds $17,924,673 across 8 Drug Manufacturers - General names. NVS ranks #3 (17.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,149 | $4,101,361 | |
| 2 | AMGN |
Amgen Inc
|
8,964 | $3,246,043 | |
| 3 | NVS |
Novartis AG
This page
|
20,231 | $3,170,602 | |
| 4 | ABBV |
AbbVie Inc.
|
10,847 | $2,729,539 | |
| 5 | PFE |
Pfizer Inc
|
94,815 | $2,283,145 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,047 | $905,539 | |
| 7 | LLY |
ELI LILLY & Co
|
740 | $887,578 | |
| 8 | SNY |
Sanofi
|
14,085 | $600,866 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,170,602 | 20,231 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $3,131,069 | 20,498 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,792,281 | 20,253 | Shares | Sole | 2026-04-01 | |
| 2025-09-30 | $2,622,379 | 20,449 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $2,488,449 | 20,564 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $2,301,839 | 20,648 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $2,104,815 | 21,630 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $2,513,071 | 21,849 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,408,125 | 22,620 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $2,204,186 | 22,787 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $2,422,371 | 23,991 | Shares | Sole | 2024-02-23 | |
| 2023-09-30 | $2,366,004 | 23,228 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $2,834,864 | 28,093 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $2,698,728 | 29,334 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $3,018,798 | 33,276 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $2,502,325 | 32,921 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $2,665,230 | 31,530 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $2,788,607 | 31,779 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $2,651,478 | 30,313 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $2,457,570 | 30,051 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $2,670,594 | 29,270 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $2,311,550 | 27,042 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $2,553,576 | 27,042 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $2,377,225 | 27,337 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,520,894 | 28,863 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,383,299 | 28,906 | Shares | Sole | 2020-06-29 | |
| No filing history on record for this holder in this stock. | ||||||